NETRIS PHARMA
Overcome cancer resistance
Lyon, France · Founded 2008
- Headquarters
- Lyon
- Employees
- 11–50
- Founded
- 2008
- Business Model
- B2B
- Website
- netrispharma.com
About
NETRIS Pharma is a clinical-stage biopharmaceutical company based in Lyon, France, developing first-in-class therapeutics that target Netrin-1 to overcome cancer resistance to chemotherapy, targeted therapy, and immunotherapy. Officially created in 2008 as the first spin-off of Centre Leon Berard and the Cancer Research Center of Lyon (CRCL), the company holds a worldwide-exclusive patent portfolio on dependence-receptor biology and partners with leading clinical, research, and corporate organizations to advance its pipeline.
Summary
NETRIS PHARMA is a Biotech company based in Lyon, France, founded in 2008.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.